EIF2AK2 and osteosarcoma: Shen, S. et al. report that STAT3 inhibitors (JSI-124, WP1066 and Stattic) caused the disruption of inhibitory STAT3-PKR interactions in human osteosarcoma U2OS cells, resulting in release and activation of PKR.